The Tobacco Control Echo Chamber: When Transparency Becomes Ideological Gatekeeping
There is something deeply revealing about the latest article from The Conversation. It is not simply what the article says. It is what it refuses to confront.
The piece frames the tobacco industry as a uniquely sinister force operating through “donations, access and secrecy” to undermine public health policy in Australia. It leans heavily on the moral panic that has defined tobacco control for decades: the idea that any interaction with industry is automatically corrupt, illegitimate and dangerous.
But in doing so, the article accidentally exposes something far more disturbing than industry lobbying.
It exposes the extraordinary hypocrisy, insularity, and ideological rigidity that now dominate Australian tobacco control.
The outrage surrounding Philip Morris giving evidence to a Senate inquiry behind closed doors has been presented as proof of democratic contamination. Yet nobody seems willing to ask the obvious question: why should an industry directly affected by legislation be barred from speaking about that legislation?
Public health activists behave as though merely hearing from tobacco companies somehow taints democracy itself. The implication is astonishing. It suggests that parliamentary inquiries should only hear from approved stakeholders, namely academics, NGOs and advocacy groups that already agree with the ideological direction of policy.
That is not transparency.
That is gatekeeping.
And it becomes even more absurd when you consider the current state of Australia’s nicotine policy landscape.
Australia is now facing an exploding illicit tobacco market, organised crime violence, widespread availability of black market cigarettes and vapes, collapsing excise revenue, and growing evidence that prohibitionist policies have created massive unintended consequences. Even mainstream reporting has begun acknowledging that years of tax escalation and regulatory extremism handed organised crime a multibillion-dollar market on a silver platter.
Yet according to sections of the tobacco control establishment, the real scandal is not the policy failure itself.
The scandal is that a tobacco company was allowed to speak privately to senators.
That tells you everything about the priorities of modern tobacco control.
The article repeatedly invokes Article 5.3 of the WHO Framework Convention on Tobacco Control, which encourages governments to protect health policy from tobacco industry influence. But what began as a reasonable safeguard against undisclosed lobbying has mutated into something far more extreme in Australia: a culture where engagement itself is treated as heresy.
The result is policymaking trapped inside an echo chamber.
Academics cite each other. Advocacy organisations reinforce each other. Government departments consult the same small network of public health figures over and over again. Dissenting voices are marginalised. Consumers are ignored. Harm reduction advocates are smeared. Smokers and vapers themselves are often treated as inconvenient obstacles rather than citizens with lived experience.
Meanwhile, the same people demanding “transparency” rarely apply equivalent scrutiny to their own networks of influence.
Where is the outrage over activist academics shaping policy while simultaneously dominating media commentary? Where is the scrutiny of taxpayer-funded public health organisations lobbying governments for policies that justify their own continued funding? Where is the discussion about ideological capture inside regulatory agencies?
Apparently influence only counts when industry does it.
The article also relies heavily on the moral framing that tobacco companies are uniquely illegitimate because they profit from harmful products. But this simplistic framing collapses under even mild scrutiny.
Governments profit enormously from tobacco. In Australia, tobacco excise became one of the Commonwealth’s most lucrative revenue streams. Public health organisations rely on ongoing tobacco control funding ecosystems. Pharmaceutical companies profit from nicotine replacement therapies and smoking cessation products. Private interests exist everywhere in health policy.
The difference is that only one set of interests is considered morally untouchable.
And this matters because policy built on moral absolutism inevitably becomes detached from reality.
Australia’s vaping policy is a perfect example.
For years, public health activists insisted harsh restrictions were necessary to “protect children.” Critics were dismissed as industry-aligned or accused of spreading tobacco talking points. Yet after the crackdown, Australia saw worsening illicit trade, flourishing black markets and growing concerns about smoking trends among young adults. The response from many within tobacco control was not humility or self-reflection.
It was demands for even more enforcement.
Even now, when inquiries are finally beginning to hear evidence about the unintended consequences of prohibition, parts of the tobacco control movement appear more offended by who is speaking than by the crisis itself.
That is not science.
It is ideology defending itself.
The irony is that the article unintentionally demonstrates the very problem it claims to oppose. It warns about secrecy while defending a policy culture that systematically excludes dissent. It condemns influence while promoting an environment where only approved narratives are allowed legitimacy. It frames itself as defending democracy while implicitly arguing that some stakeholders should never be heard at all.
A mature democracy should be capable of hearing evidence from everyone, industry, academics, consumers, law enforcement, retailers, public health advocates and critics alike, without collapsing into moral hysteria.
Hearing evidence is not endorsement.
Debate is not corruption.
Transparency does not mean ideological purity.
And perhaps the greatest danger facing Australian nicotine policy today is not tobacco industry lobbying. It is the growing belief within parts of the public health establishment that they alone possess the moral authority to decide who is allowed to participate in the conversation.



Another excellent, spot on commentary from Alan Gor. Decades ago, tobacco companies were united in flagrant dishonesty, dissembling and exaggerating doubt when near certainty was thoroughly justified. They denied smoking caused cancer when they possessed compelling evidence that was the case. The result was that tobacco companies and their staff were ostracised and rightly so. But today it’s tobacco control that does the lying, dissembling, dishonesty and dirty tricks. When faced with the question of relative safety of smoking versus vaping, tobacco control asserts that evidence of the harm from vaping is “emerging” - without actually providing any evidence. Or claiming vaping may be as dangerous as smoking knowing that their assertions won’t be challenged. Tobacco control wants you to believe that the 100-200 low/trace concentration chemicals in vaping aerosol are as dangerous as the 7,000 high concentration chemicals in cigarette smoke which include 70 known carcinogens and carbon monoxide! Yeah, pull the other leg! The world constantly changes. Now tobacco control and tobacco companies have largely flipped. How much longer should tobacco companies be ostracised? Should this be forever even when the world’s largest traded tobacco company, Philip Morris International, now earns 42% of its revenue from safer, smoke-free nicotine products? And British American Tobacco, the world’s second largest traded tobacco company, now earns 18% of its revenue from these products? In 2022, Philip Morris International announced it’s aspirations for 2025. It wanted to achieve 100 markets where PMI smoke-free products are available for sale; over 250 smoke-free product shipment volume (billion units); net revenue of at least $1 billion from wellness and healthcare products; over 50% of markets where PMI smoke-free products are available for sale that are low-and middle-income; over 30% smoke-free product shipment ratio (smoke-free/total); over 50% adjusted net revenue from smoke-free products; less than 550 combustible product shipment volume (billion units); about 40% reduction in combustible product shipment volumes compared to 2015; over 40 million estimated number of users who have switched to PMI‘s smoke-free products and stopped smoking. Why doesn’t tobacco control see whether PMI achieved its target? Major tobacco companies have changed dramatically. Is tobacco control prepared to admit that the world has changed? Or just continue demonisation of tobacco companies forever?
The mantra of the big public health/academia/health bureaucrat/socialist politician echo chamber. We are right because we agree with ourselves. If anyone has a different view they are part of a big tobacco conspiracy and we will put our fingers in our ears and go lalalalalala